Blog

PNA Medical Corner: Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomized, phase 3 trial

The third PNA Medical Corner for this month focuses on a study co-authored by PNA member Dr. Maria Fleseriu and a longtime friend of the PNA, Dr. Annamaria Colao. It looks at several medical treatments for acromegaly.

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, Pronin V, Raverot G, Shimon I, Lievre KK, Fleck J, Aout M, Pedroncelli AM, Colao A; on behalf of the Pasireotide C2402 Study Group.
Lancet Diabetes Endocrinol. 2014 Sep 23. pii: S2213-8587(14)70169-X. doi: 10.1016/S2213-8587(14)70169-X. [Epub ahead of print]